nmm 22 4500 ICPSR02564 MiAaI m f a u cr mn mmmmuuuu 130521s2000 miu f a eng d (MiAaI)ICPSR02564 MiAaI MiAaI Crack, Powder Cocaine, and Heroin [electronic resource] Drug Purchase and Use Patterns in Six Cities in the United States, 1995-1996 K. Jack Riley 2012-08-22 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2000 ICPSR 2564 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This study was designed to address the practical and policy implications of various drug market participation patterns. In 1995, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice (NIJ) collaborated on a project called the Procurement Study. This study was executed as an addendum to NIJ's Drug Use Forecasting (DUF) program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]) with the goal of extending previous research in which heroin users were interviewed on various aspects of drug market activity. The present study sought to explore additional features of drug market participation and use, both within and across drug types and cities, and included two additional drugs -- powder cocaine and crack cocaine. Data were collected from recently arrested users of powder cocaine, crack cocaine, and heroin in six DUF cities (Chicago, New York, Portland, San Diego, San Antonio, and Washington, DC). Each of the three files in this collection, Crack Data (Part 1), Heroin Data (Part 2), and Powder Cocaine Data (Part 3), is comprised of data from a procurement interview, urine test variables, and a DUF interview. During the procurement interview, information was collected on purchase and use patterns for specific drugs. Variables from the procurement interview include the respondent's method of using the drug, the term used to refer to the drug, whether the respondent bought the drug in the neighborhood, the number of different dealers the respondent bought the drug from, how the respondent made the connection with the dealer (i.e., street, house, phone, beeper, business/store, or friends), their main drug source, whether the respondent went to someone else if the source was not available, how the respondent coped with not being able to find drugs to buy, whether the respondent got the drug for free, the means by which the respondent obtained money, the quantity and packaging of the drug, and the number of minutes spent searching for, traveling to, and waiting for their last purchase. Urine tests screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography). Data from the DUF interview provide detailed information about each arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the DUF interview instrument also included alcohol/drug treatment history, information about whether arrestees had ever injected drugs, and whether they were influenced by drugs when the crime that they were charged with was committed. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had had prior arrests in the past 12 months. Demographic data include the age, race, sex, educational attainment, marital status, employment status, and living circumstances of each respondent. Cf.: http://dx.doi.org/10.3886/ICPSR02564.v1 crack cocaine icpsr crime patterns icpsr demographic characteristics icpsr drug abuse icpsr drug dependence icpsr drug offenders icpsr drug related crimes icpsr drug testing icpsr drug traffic icpsr drug treatment icpsr drug use icpsr drugs icpsr heroin icpsr substance abuse icpsr trends icpsr urinalysis icpsr ADAM/DUF Program icpsr arrests icpsr cocaine icpsr NAHDAP I. National Addiction and HIV Data Archive Program NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System Riley, K. Jack Inter-university Consortium for Political and Social Research. ICPSR (Series) 2564 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02564.v1 nmm 22 4500 ICPSR04020 MiAaI m f a u cr mn mmmmuuuu 130521s2004 miu f a eng d (MiAaI)ICPSR04020 MiAaI MiAaI Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2003 [electronic resource] United States Department of Justice. National Institute of Justice 2006-03-30 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2004 ICPSR 4020 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2003 up to four separate times (quarterly) during the year in 39 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. The ADAM program in 2003 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult male and female files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) for males, weights. Cf.: http://dx.doi.org/10.3886/ICPSR04020.v1 demographic characteristics icpsr drug offenders icpsr drug related crimes icpsr drug testing icpsr drug treatment icpsr drug use icpsr drugs icpsr substance abuse icpsr trends icpsr urinalysis icpsr drug dependence icpsr ADAM/DUF Program icpsr alcohol abuse icpsr arrests icpsr crime patterns icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Justice. National Institute of Justice Inter-university Consortium for Political and Social Research. ICPSR (Series) 4020 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR04020.v1 nmm 22 4500 ICPSR32321 MiAaI m f a u cr mn mmmmuuuu 130521s2011 miu f a eng d (MiAaI)ICPSR32321 MiAaI MiAaI Arrestee Drug Abuse Monitoring Program II in the United States, 2010 [electronic resource] Dana Hunt , William Rhodes 2011-11-04 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2011 ICPSR 32321 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates. Cf.: http://dx.doi.org/10.3886/ICPSR32321.v1 ADAM/DUF Program icpsr alcohol abuse icpsr arrests icpsr crime patterns icpsr demographic characteristics icpsr drug abuse icpsr drug dependence icpsr drug offenders icpsr drug related crimes icpsr drug testing icpsr drug treatment icpsr drug use icpsr drugs icpsr susbstance abuse icpsr trends icpsr urinalysis icpsr NAHDAP I. National Addiction and HIV Data Archive Program NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System Hunt, Dana Rhodes, William Inter-university Consortium for Political and Social Research. ICPSR (Series) 32321 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR32321.v1 nmm 22 4500 ICPSR30061 MiAaI m f a u cr mn mmmmuuuu 130521s2011 miu f a eng d (MiAaI)ICPSR30061 MiAaI MiAaI Arrestee Drug Abuse Monitoring Program II in the United States, 2009 [electronic resource] Dana Hunt , William Rhodes 2011-02-24 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2011 ICPSR 30061 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates. Cf.: http://dx.doi.org/10.3886/ICPSR30061.v1 trends icpsr urinalysis icpsr drug treatment icpsr drug use icpsr drugs icpsr susbstance abuse icpsr demographic characteristics icpsr drug abuse icpsr drug dependence icpsr drug offenders icpsr drug related crimes icpsr drug testing icpsr ADAM/DUF Program icpsr alcohol abuse icpsr arrests icpsr crime patterns icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program NACJD XI. Drugs, Alcohol, and Crime Hunt, Dana Rhodes, William Inter-university Consortium for Political and Social Research. ICPSR (Series) 30061 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR30061.v1 nmm 22 4500 ICPSR02155 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR02155 MiAaI MiAaI Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1991 [electronic resource] Household and Non-Household Populations United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-07-16 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 2155 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The DC Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient populations and of women delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are under-represented in household surveys. The DC*MADS: Household and Non-household Populations examines the prevalence of tobacco, alcohol, and drug use among members of household and non-household populations aged 12 and older in the District of Columbia Metropolitan Statistical Area (DC MSA). The study also examines the characteristics of three drug-abusing sub-groups: crack-cocaine, heroin, and needle users. The household sample was drawn from the 1991 National Household Survey on Drug Abuse (NHSDA). The non-household sample was drawn from the DC*MADS Institutionalized and Homeless and Transient Population Studies. Data include demographics, needle use, needle-sharing, and use of tobacco, alcohol, cocaine, crack, inhalants, marijuana, hallucinogens, heroin, sedatives, stimulants, psychotherapeutics (non-medical use), tranquilizers, and analgesics. Cf.: http://dx.doi.org/10.3886/ICPSR02155.v3 alcohol icpsr cocaine icpsr crack cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr hallucinogens icpsr heroin icpsr homeless persons icpsr inhalants icpsr marijuana icpsr sedatives icpsr smoking icpsr stimulants icpsr tranquilizers icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD V. Health and Well-Being ICPSR XVI.A. Social Indicators, United States SAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS) NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 2155 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02155.v3 nmm 22 4500 ICPSR02347 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR02347 MiAaI MiAaI Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1992 [electronic resource] Drug Use Among DC Women Delivering Live Births in DC Hospitals United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-12-15 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 2347 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Washington, DC, Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are underrepresented in household surveys. The DC*MADS: Drug Use Among Women Delivering Livebirths in DC Hospitals was designed to examine the nature and extent of drug use among women delivering live births in eight Washington, DC, hospitals participating in the study. Data from the questionnaires include prenatal care, health problems during pregnancy, pregnancy drug use history, needle use, polysubstance use, patterns of use, respondent's general experiences with drug use, including perceptions of the risks and consequences of use, occurrence of psychological and emotional problems, income and insurance coverage, treatment experiences, and maternal and infant outcomes. Medical records were abstracted from the women and their infants to document medical problems. Abstracted data on the mothers included demographics, discharge diagnoses, disposition at discharge, and results of urine screens. Abstracted data on infants included delivery information, status at discharge, discharge diagnoses/procedures, and first urine toxicology screen results. Cf.: http://dx.doi.org/10.3886/ICPSR02347.v2 alcohol consumption icpsr cocaine icpsr demographic characteristics icpsr drug testing icpsr drug use icpsr drugs icpsr hallucinogens icpsr health care access icpsr alcohol icpsr heroin icpsr infants icpsr inhalants icpsr insurance coverage icpsr live births icpsr marijuana icpsr mental health icpsr population characteristics icpsr pregnancy icpsr prenatal care icpsr reproductive history icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr urban population icpsr women icpsr RCMD V. Health and Well-Being SAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS) NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System ICPSR XVI.A. Social Indicators, United States NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 2347 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02347.v2